APA

Sloane P. A., Shastry S., Wilhelm A., Courville C., Tang L. P., Backer K., Levin E., Raju S. V., Li Y., Mazur M., Byan-Parker S., Grizzle W., Sorscher E. J., Dransfield M. T. & Rowe S. M. (20121127). A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease. : PloS one.

Chicago

Sloane Peter A, Shastry Suresh, Wilhelm Andrew, Courville Clifford, Tang Li Ping, Backer Kyle, Levin Elina, Raju S Vamsee, Li Yao, Mazur Marina, Byan-Parker Suzanne, Grizzle William, Sorscher Eric J, Dransfield Mark T and Rowe Steven M. 20121127. A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease. : PloS one.

Harvard

Sloane P. A., Shastry S., Wilhelm A., Courville C., Tang L. P., Backer K., Levin E., Raju S. V., Li Y., Mazur M., Byan-Parker S., Grizzle W., Sorscher E. J., Dransfield M. T. and Rowe S. M. (20121127). A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease. : PloS one.

MLA

Sloane Peter A, Shastry Suresh, Wilhelm Andrew, Courville Clifford, Tang Li Ping, Backer Kyle, Levin Elina, Raju S Vamsee, Li Yao, Mazur Marina, Byan-Parker Suzanne, Grizzle William, Sorscher Eric J, Dransfield Mark T and Rowe Steven M. A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease. : PloS one. 20121127.